Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Nuevocor

Request full access

Operates as a preclinical-stage biotech company

Singapore, SingaporeFounded 2020Biotech & Life Sciences

About Nuevocor

Nuevocor is a biotechnology startup that operates in the field of genetic medicine. The company's primary focus is on the development of treatments for lamin dilated cardiomyopathy, a heart condition that can lead to heart failure. Nuevocor's lead program, NVC-001, is a genetic medicine designed to treat this condition.

The company's unique approach to treatment involves the use of their proprietary PrOSIA mechanobiology platform. This platform allows Nuevocor to design genetic medicines that address the biomechanical root cause of diseases, rather than just treating single gene mutations. This is a significant departure from traditional gene therapy and could potentially benefit a larger number of patients.

Nuevocor's business model is based on the research, development, and commercialization of these genetic medicines. The company's primary clients are patients suffering from diseases that can be treated with their innovative approach. The market for such treatments is vast, given the prevalence of genetic diseases and the limitations of current treatment options.

The company generates revenue through the sale of its genetic medicines. As the company's treatments are still in the development stage, it is likely that they also rely on funding from investors and grants for research and development.

Nuevocor positions itself at the forefront of a new generation of genetic medicine companies. Their innovative pathway-centric approach could potentially revolutionize the treatment of genetic diseases, making them a company to watch in the biotech sector.

Source: Dealroom company data

At a glance

Status
Operational
Employees
29
Open positions
None listed
Dealroom signal
67.1/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing May 2025 $45M $180M Boehringer Ingelheim Venture Fund · Kurma Partners · EDBI · Highlight Capital ↗
EARLY VCOther financing Nov 2022 $12M $120M EDBI · Boehringer Ingelheim Venture Fund · Seeds Capital · Everjoy Fortune ↗
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Nuevocor website traffic

Latest recorded traffic for Nuevocor is 2.9K monthly website visits, up 559.1% over the last three months. Nuevocor's team declined 6.5% over the past year.

Latest monthly visits2.9K 3-month web change+559.1% 1-year team growth-6.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Nuevocor in the Singapore ecosystem

Live from Dealroom

The Nuevocor office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A11 investors entered at this stage

  • Boehringer Ingelheim Venture Fund
  • EVX Ventures
  • EDBI
  • Seeds Capital
  • Everjoy Fortune
  • ZORA Ventures
  • Hyfinity Investments
  • Kurma Partners
  • Angelini Ventures
  • Highlight Capital
  • ClavystBio
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇸🇬 Singapore70.8%
🇫🇷 France12.5%
🇭🇰 Hong Kong4.2%
🇮🇹 Italy4.2%
🇺🇸 United States4.2%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Nuevocor on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nuevocor’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.